AstraZeneca · conference-presentation
AstraZeneca | Investor Day Presentation Deck | 86 slides
86 pages · 4 arc beats · 2 loops
AstraZeneca | Investor Day Presentation Deck | 86 slides
AstraZeneca · 2021-03 arc beats above · slides in the middle · loops below · scroll → 2 LOOPS
151015202530354045505560657075808586
Deck intelligence map
4 coverage by narrative range · generated from this deck JSON
Narrative range 17 total
Metadata
Components
Metrics
Tools
Frameworks
Beats
Loops
Problem 2 slides 100% 2/2 slides 100% 2/2 slides · 10 hits — 0/2 slides
100% 2/2 slides — 0/2 slides
100% 2/2 slides 100% 2/2 slides Solution 6 slides 100% 6/6 slides 100% 6/6 slides · 59 hits — 0/6 slides
66.7% 4/6 slides · 6 hits 16.7% 1/6 slides 100% 6/6 slides 66.7% 4/6 slides Market Size 6 slides 100% 6/6 slides 100% 6/6 slides · 45 hits — 0/6 slides
16.7% 1/6 slides — 0/6 slides
100% 6/6 slides — 0/6 slides
Team 3 slides 100% 3/3 slides 100% 3/3 slides · 10 hits — 0/3 slides
33.3% 1/3 slides — 0/3 slides
100% 3/3 slides — 0/3 slides
Slide inventory
86 every slide · same image gating as the playbook
04
The slide uses a high-contrast table to contrast prevalence vs mortality across different disease states.diagnose_problem
05
The slide uses a three-column structure: current portfolio, historical performance chart, and future pipeline.analyze_data
06
The slide uses stacked bar charts to show revenue composition by region (US, Europe, ERoW, EM) for each product.analyze_data
07
The slide uses color-coded regions on a world map with callout circles to summarize regional metrics.establish_context
08
The slide uses a consistent visual language of bar charts with trend lines to communicate growth.analyze_data
09
The slide uses a three-column layout to frame the problem, the current solution/progress, and the strategic approach.size_opportunity
10
The slide uses a three-column layout to present market data and strategic initiatives.summarize
Open slide detailBeat · Solution
13
The slide lists 6 points (5R + digital), though the title refers to the 5R framework.analyze_data
14
The slide uses a stacked bar chart to compare AstraZeneca (first bar) against five competitors (R, P, N, J, M).compare_peers
16
The slide outlines a multi-stage R&D process involving data integration, AI analysis, and biological validation.present_solution
Open slide detailLoop · Hypothesis Test
17
The slide uses a grid-based categorization of drug modalities.present_framework
Open slide detailLoop · Hypothesis Test
18
The slide uses a three-column layout to present project metrics, chemical safety improvements, and biological efficacy results.summarize
Open slide detailLoop · Hypothesis Test
19
The slide uses a combination of process flow, microscopy imagery, and a bar chart to demonstrate the therapeutic potential of HVP cells.illustrate_case
Open slide detailLoop · Hypothesis Test
20
The central cycle diagram illustrates the efficiency gains (1 vs 3 years, 1000 vs 2500 compounds).present_solution
Open slide detailLoop · Hypothesis Test
21
The slide uses a four-column layout to present distinct technological approaches to clinical trial optimization.summarize
Open slide detailLoop · Hypothesis Test
22
The slide uses a process flow at the top and a four-pillar framework at the bottom to explain the trial's methodology.present_solution
Open slide detailLoop · Hypothesis Test
23
The slide uses a color-coded grid to distinguish between highlighted pipeline assets and others, with extensive footnotes detailing specific drug mechanisms andother
26
The slide uses a Gantt-style chart to visualize the compression of development phases.present_solution
27
The slide uses a comparison structure between clinical trial data and real-world evidence.summarize
29
The slide uses a three-column layout to present product features, scientific data, and clinical trial status.diagnose_problem
32
The slide acts as a logistical guide for a multi-session virtual event.plan_implementation
36
The slide uses a four-column layout to map disease areas to specific patient outcomes, prevalence data, and therapeutic candidates.prioritize
Open slide detailBeat · Market Size
37
Phase I SAD data presented with dose-response curves for 20mg, 30mg, 60mg, 90mg, and 120mg cohorts.analyze_data
Open slide detailBeat · Market Size
38
Slide presents data from PROMIS observational trial and SATELLITE Phase IIa trial.summarize
Open slide detailBeat · Market Size
39
The slide uses a three-panel structure to compare preclinical rodent models (left/center) with clinical trial data (right).analyze_data
Open slide detailBeat · Market Size
40
The slide combines a biological mechanism diagram with two bar charts showing clinical efficacy data.analyze_data
Open slide detailBeat · Market Size
41
The slide uses color coding to distinguish between highlighted medicines and others in the pipeline.plan_implementation
Open slide detailBeat · Market Size
49
The slide uses a timeline framework to demonstrate clinical efficacy over time.present_framework
51
Includes references to specific clinical stages and therapeutic approaches (Farxiga, Lokelma, roxadustat).diagnose_problem
52
Slide 6 of a presentation. Combines patient demographics, clinical trial results (DIALIZE), and revenue growth.analyze_data
54
The slide uses a process-oriented layout to map drug development stages to a timeline of upcoming news events.plan_implementation
60
Includes speaker names and titles, date, and webinar registration link.front_matter
62
The slide uses a three-column layout to present quantitative data points for each disease category, supported by footnotes.frame_problem
63
The slide uses a three-column layout to categorize strategic focus areas.present_framework
64
The slide uses a combination of a biological pathway diagram and a violin plot to demonstrate drug efficacy.illustrate_case
65
Includes longitudinal pharmacodynamic data for IL5 and IL13 reduction and a list of Phase II trials with patient counts and timelines.analyze_data
66
The slide uses a combination of line charts and bar charts to demonstrate efficacy, alongside a molecular pathway diagram.present_solution
67
Includes line chart for pain scores over time, forest plot for NGF suppression efficacy, and trial status list.analyze_data
68
The slide uses color coding to distinguish between highlighted medicines and other pipeline medicines.plan_implementation
73
Includes speaker names and titles, date, and webinar registration link.front_matter
75
The slide uses a three-column layout to contrast disease statistics with clinical evidence for treatment.diagnose_problem
76
Slide uses a split-layout comparing two distinct product strategies (COPD vs Asthma).quantify_opportunity
77
The slide uses a combination of donut charts for market penetration and a grouped bar chart for clinical trial efficacy data.analyze_data
78
The slide uses a matrix-like structure to map biological mechanisms to specific drug candidates and development timelines.plan_implementation
79
The slide uses a three-column layout to present distinct clinical trial outcomes.summarize
80
The slide uses a color-coded legend to distinguish highlighted presentation items from other pipeline medicines.plan_implementation
85
The slide is a continuation of a list of publications, specifically focusing on the PATHWAY study.cite_precedent